Financial SI-BONE, Inc. Reports Financial Results for the Third Quarter 2024 and Updates Guidance byJosh SandbergNovember 13, 2024
Financial Hospitals Spine SI-BONE Receives Transitional Pass-Through Payment Status for iFuse Bedrock Granite™ byJosh SandbergNovember 5, 2024
Spine SI-BONE, Inc. Announces First-In-Patient Procedures with FDA Breakthrough Device for Pelvic Fracture Fixation byJosh SandbergOctober 10, 2024
Regulatory Spine SI-BONE, Inc. Receives 510(k) Clearance and FDA Breakthrough Device Designation for Pelvic Fracture Fixation System byJosh SandbergAugust 20, 2024
Financial SI-BONE, Inc. Reports Financial Results for the Second Quarter 2024 byJosh SandbergAugust 5, 2024
Spine Top Stories Osteotec announces exclusive UK and Ireland distribution agreement with SI-BONE byTim AllenMay 16, 2024
Spine Top Stories SI-BONE Expands Portfolio with the Launch of New Offering for the iFuse Bedrock Granite Implant System and Completes Inaugural Surgical Procedures byJosh SandbergMay 7, 2024
Financial SI-BONE, Inc. Reports Record Fourth Quarter and Full Year 2023 Financial Results and Issues 2024 Guidance byJosh SandbergFebruary 26, 2024
Regulatory Spine SI-BONE, Inc. Receives FDA 510(k) Clearance for a Smaller Diameter iFuse Bedrock Granite Implant with an Expanded Indication and Application byJosh SandbergJanuary 30, 2024
Financial SI-BONE, Inc. Reports Record Financial Results for the Third Quarter 2023 and Raises Annual Guidance byJosh SandbergNovember 6, 2023
